MENU
+Compare
ALBT
Stock ticker: NASDAQ
AS OF
Nov 19, 12:07 PM (EDT)
Price
$1.54
Change
+$0.02 (+1.32%)
Capitalization
5.83M

ALBT Avalon GloboCare Corp Forecast, Technical & Fundamental Analysis

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management... Show more

ALBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ALBT with price predictions
Nov 18, 2025

Momentum Indicator for ALBT turns negative, indicating new downward trend

ALBT saw its Momentum Indicator move below the 0 level on October 20, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 99 similar instances where the indicator turned negative. In of the 99 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ALBT entered a downward trend on November 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALBT advanced for three days, in of 209 cases, the price rose further within the following month. The odds of a continued upward trend are .

ALBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (13.277). P/E Ratio (0.000) is within average values for comparable stocks, (57.436). ALBT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.021). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (1.653) is also within normal values, averaging (9.679).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ALBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
ALBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of software solutions

Industry RealEstateDevelopment

Profile
Fundamentals
Details
Industry
Packaged Software
Address
4400 Route 9 South
Phone
+1 732 780-4400
Employees
6
Web
https://www.avalon-globocare.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CX10.210.21
+2.10%
Cemex SAB de CV
ICHR14.520.23
+1.61%
Ichor Holdings
PFS18.010.24
+1.35%
Provident Financial Services
FLGC7.460.01
+0.13%
Flora Growth Corp
CSBR6.73-0.02
-0.30%
Champions Oncology

ALBT and Stocks

Correlation & Price change

A.I.dvisor tells us that ALBT and KW have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALBT and KW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALBT
1D Price
Change %
ALBT100%
-13.88%
KW - ALBT
23%
Poorly correlated
-0.63%
HOUS - ALBT
21%
Poorly correlated
-0.32%
CWK - ALBT
18%
Poorly correlated
+0.14%
UK - ALBT
12%
Poorly correlated
N/A
DUO - ALBT
12%
Poorly correlated
-2.22%
More